MDA5 variants trade antiviral activity for protection from autoimmune disease

Chris Wallace1,2, Rahul Singh3,4, Yorgo Modis5,6

  • 1Cambridge Institute of Therapeutic Immunology and Infectious Disease, University of Cambridge School of Clinical Medicine, Cambridge, UK. cew54@cam.ac.uk.

PubMed

Insights

Loss-of-function variants in MDA5 offer protection against type 1 diabetes and other autoimmune diseases but increase inflammatory bowel disease risk. This suggests a trade-off between viral defense and autoimmune conditions.

Area of Science:

  • Immunology
  • Genetics
  • Human Disease

Background:

  • Loss-of-function variants in MDA5, a sensor for viral double-stranded RNA, are linked to type 1 diabetes (T1D) protection and inflammatory bowel disease (IBD) risk.
  • The relationship between MDA5 variants and various autoimmune diseases remains incompletely understood.

Purpose of the Study:

  • To investigate the association of MDA5 loss-of-function variants with multiple autoimmune diseases and IBD.
  • To determine if T1D-protective MDA5 variants confer protection against other autoimmune conditions.

Main Methods:

  • Fine-mapping analysis of four large genome-wide association study (GWAS) datasets.
  • Statistical analysis of odds ratios for autoimmune protection and IBD risk associated with MDA5 variants.

Main Results:

  • T1D-protective MDA5 loss-of-function variants also protect against psoriasis and hypothyroidism.
  • These variants increase the risk of IBD, with a linear proportionality between autoimmune protection and IBD risk.
  • Rare MDA5 variants showed larger effect sizes for both autoimmune protection and IBD risk compared to common variants.

Conclusions:

  • MDA5 genetic variants present a fitness trade-off between viral clearance and autoimmune tissue damage.
  • The findings highlight the complex role of MDA5 in balancing immune responses to pathogens and self-antigens.